Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia

Medicine & Life Sciences

• Galanin 80%
• Frontotemporal Dementia 73%
• Neuropeptide Y 68%
• Somatostatin 61%
• Neuropeptides 60%
• Cerebrospinal Fluid 51%
• Alzheimer Disease 45%
• Radioimmunoassay 18%
• Mass Spectrometry 17%
• Lasers 15%
• Alzheimer disease, familial, type 3 10%
• Peptide Fragments 8%
• Neurodegenerative Diseases 5%
• High Pressure Liquid Chromatography 5%
• Peptides 4%
• Enzymes 3%
• Proteins 2%
• Therapeutics 1%

Chemical Compounds

• Galanin 100%
• Neuropeptide Y 88%
• Somatostatin 80%
• Laser Desorption 22%
• Time-of-Flight Mass Spectrometry 19%
• Peptide 7%
• Disorder 5%
• Biomaterial 5%
• Metabolic 5%
• Pharmacological Metabolism 5%
• Amount 2%
• Protein 2%